| Literature DB >> 35439842 |
Olaf Morgenroth1, Lars-Eric Petersen2, Norbert Frey3, Alexander Reinecke4.
Abstract
AIMS: Implantation of a left ventricular assist device (LVAD) is an established treatment option for patients with advanced heart failure. However, apart from its challenging medical management, it comes with serious psychological implications. Empirical evidence suggests that self-compassion, a self-regulation strategy for countering negative self-directed emotions, might be a promising approach in facilitating psychological adjustment also in LVAD patients. The aims of the present study were to investigate self-compassion as a protective factor for anxiety and depressive symptoms, to test whether taking a decentred perspective mediates these effects, and to explore whether self-compassion predicts the clinically rated functional health status. METHOD ANDEntities:
Keywords: Anxiety; Depression; Functional health status; Heart failure; LVAD; Self-compassion
Mesh:
Year: 2022 PMID: 35439842 PMCID: PMC9288784 DOI: 10.1002/ehf2.13931
Source DB: PubMed Journal: ESC Heart Fail ISSN: 2055-5822
Descriptive statistics of study variables
| Measure |
| ( |
| 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|---|---|---|
| 1. Anxiety (HADS) | 6.18 | 3.92 | 0.75 | |||||
| 2. Depression (HADS) | 6.60 | 3.82 | 0.71 | 0.63 | ||||
| 3. Self‐compassion (SCS) | 3.39 | 0.50 | 0.84 | −0.28 | −0.34 | |||
| 4. Distanced perspective (EQ) | 9.20 | 3.77 | 0.83 | −0.52 | −0.34 | 0.48 | ||
| 5. Accepting self‐perception (EQ) | 11.60 | 2.52 | 0.54 | −0.27 | −0.43 | 0.51 | 0.50 | |
| 6. NYHA class ( | 0.24 | 0.27 | −0.38 | −0.33 | −0.40 |
α = Cronbach's alpha; correlations with NYHA class are Kendall's τb; and all other correlations are Bravais–Pearson r.
P < 0.05,
P < 0.01 two‐tailed.
Descriptive statistics of clinical information
| Characteristic | Total sample | HADS‐A ≥ 8 | HADS‐D ≥ 8 |
|---|---|---|---|
|
| |||
| Treatment rationale | |||
| Destination therapy | 30 (66.7) | 9 (45) | 10 (43.5) |
| Bridge to transplantation | 15 (33.3) | 11 (55) | 13 (56.5) |
| Age at LVAD implantation (years) | 58.6 (10.8) | 56.4 (10.8) | 57.7 (12.3) |
| Period since LVAD implantation (years) | 2.1 (1.7) | 1.3 (1.5) | 1.6 (1.8) |
| Adverse events | |||
| None | 24 (53.6) | 10 (50) | 11 (47.8) |
| Reoperation | 7 (15.6) | 3 (15) | 3 (13) |
| Gastrointestinal bleeding | 6 (13.3) | 1 (5) | 3 (13) |
| Infection | 3 (6.7) | 2 (10) | 2 (8.7) |
| Other events | 7 (15.6) | 4 (20) | 4 (17.4) |
| Heart failure aetiology | |||
| Coronary heart disease | 22 (48.9) | 10 (50) | 12 (52.8) |
| Dilated cardiomyopathy | 22 (48.9) | 10 (50) | 11 (47.2) |
| Other aetiologies | 1 (2.2) | 0 | 0 |
| Severe comorbidity | 3 (6.7) | 0 | 0 |
| Number of drugs | 14 (3.6) | 13.9 (3.3) | 14 (3.1) |
| Psychotropic medication (yes) | 8 (17.8) | 6 (30) | 6 (26.1) |
| NYHA classification | |||
| Class I | 10 (22.2) | 3 (15) | 3 (13) |
| Class II | 33 (73.3) | 15 (75) | 18 (78.3) |
| Class III | 2 (4.4) | 2 (10) | 2 (8.7) |
| Class IV | 0 | 0 | 0 |
| Body mass index (BMI) | 27.2 (4.9) | 27.1 (3.9) | 25.8 (3.9) |
Total sample N = 45; HADS‐A ≥ 8: N = 20; HADS‐D ≥ 8: N = 23.
Multiple entries possible.
Figure 1Multiple parallel mediation models for anxiety (A) and depressive symptoms (B); lowercase letters with subscripts indicate standardized path coefficients; *P < 0.05; **P < 0.01; ***P < 0.001. c = total effect, c' = direct effect.
Multiple parallel mediation model for anxiety
| Effect | Coefficient | SE |
| 95% CI [LB; UB] | Standardized coefficient |
|---|---|---|---|---|---|
| Direct effects | |||||
| c' (SC → ANX) | −0.15 | 1.121 | −0.14 | [−2.41; 2.11] | −0.02 |
| a1 (SC → ASP) | 2.59 | 0.641 | 4.03 | [1.29; 3.89] | 0.51 |
| a2 (SC → DP) | 3.69 | 0.951 | 3.88 | [1.77; 5.60] | 0.48 |
| b1 (ASP→ANX) | −0.03 | 0.211 | −0.15 | [−0.45; 0.39] | −0.02 |
| b2 (DP → ANX) | −0.52 | 0.111 | −4.57 | [−0.75; −0.29] | −0.52 |
| Total indirect effect | |||||
| a1 × b1 + a2 × b2 (SC → ASP→ANX + SC → DP → ANX) | −2.00 | 0.862 | [−3.82; −0.37]2 | −0.26 | |
| Specific indirect effects | |||||
| a1 × b1 (SC → ASP → ANX) | −0.08 | 0.662 | [−1.32; 1.40]2 | −0.01 | |
| a2 × b2 (SC → DP → ANX) | −1.92 | 0.672 | [−3.36; −0.76]2 | −0.25 | |
| Contrast specific indirect effects | |||||
| a1 × b1—a2 × b2 (SC → ASP → ANX)—(SC → DP → ANX) | 1.84 | 1.022 | [0.03; 4.18]2 | 0.24 | |
| Total effect | |||||
| c (SC → anxiety) | −2.15 | 1.141 | −1.89 | [−4.45; 0.15] | −0.28 |
Superscripts: 1 = heteroscedasticity consistent standard error (Huber–White); 2 = bootstrap‐based (N = 5000) standard errors and 95% confidence interval (CI) for indirect effects; LB = lower bound; UB = upper bound.
P < 0.05,
P < 0.01,
P < 0.001.
Multiple parallel mediation model for depressive symptoms
| Effect | Coefficient | SE |
| 95% CI [LB; UB] | Standardized coefficient |
|---|---|---|---|---|---|
| Direct effects | |||||
| c' (SC → DEP) | −0.92 | 1.121 | −0.82 | [−3.19; 1.35] | −0.12 |
| a1 (SC → ASP) | 2.59 | 0.641 | 4.03 | [1.29; 3.89] | 0.51 |
| a2 (SC → DP) | 3.69 | 0.951 | 3.88 | [1.77; 5.60] | 0.48 |
| b1 (ASP → DEP) | −0.47 | 0.211 | −2.19 | [−0.90; −0.04] | −0.31 |
| b2 (DP → DEP) | −0.13 | 0.121 | −1.09 | [−0.38; 0.11] | −0.13 |
| Total indirect effect | |||||
| a1 × b1 + a2 × b2 (SC → ASP → DEP + SC → DP → DEP) | −1.70 | 0.852 | [−3.44; −0.10]2 | −0.22 | |
| Specific indirect effects | |||||
| a1 × b1 (SC → ASP → DEP) | −1.21 | 0.792 | [−3.09; 0.04]2 | −0.16 | |
| a2 × b2 (SC → DP → DEP) | −0.49 | 0.552 | [−1.46; 0.78]2 | −0.06 | |
| Contrast specific indirect effects | |||||
| a1 × b1—a2 × b2 (SC → ASP → DEP)—(SC → DP → DEP) | −0.72 | 1.082 | [−3.34; 0.93]2 | −0.09 | |
| Total effect | |||||
| c (SC → DEP) | −2.62 | 1.151 | −2.27 | [−4.95; −0.29] | −0.34 |
Superscripts: 1 = heteroscedasticity consistent standard error (Huber–White); 2 = bootstrap‐based (N = 5000) standard errors and 95% confidence‐interval (CI) for indirect effects; LB = lower bound; UB = upper bound.
P < 0.05,
P < 0.01,
P < 0.001.
Multiple logistic regression models predicting functional health status from self‐compassion controlling for anxiety (Model A) and depressive symptoms (Model B)
|
| SE |
| OR | 95% CI OR [LB; UB] | |
|---|---|---|---|---|---|
| Model A (controlling for anxiety) | |||||
| Constant | 9.441 | 4.555 | 0.038 | ||
| Anxiety (HADS) | 0.041 | 0.113 | 0.717 | 1.042 | [0.835; 1.299] |
| Self‐compassion (SCS) | −2.393 | 1.142 | 0.036 | 0.091 | [0.010; 0.858] |
|
| |||||
| Model B (controlling for depressive symptoms) | |||||
| Constant | 8.213 | 4.077 | 0.044 | ||
| Depressive symptoms (HADS) | 0.133 | 0.127 | 0.293 | 1.142 | [0.891; 1.464] |
| Self‐compassion (SCS) | −2.192 | 1.063 | 0.039 | 0.112 | [0.014; 0.898] |
|
| |||||
LB, lower bound; OR, odds ratio; UB, upper bound.
Coding: 0 = NYHA class I, 1 = NYHA class II/III.
Heteroscedasticity consistent standard error (Huber–White).